MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Integrated Clinical Research Intern Program: Impact Upon Recruitment of Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention.

    L. Lemon, A. Faraday, J. Nevins, M. Nygard, M. Mcmahon (Cincinnati, USA)

    Objective: To discuss the development and benefit of an online internship program created to expand recruitment and retention within a PD cohort and introduce students…
  • 2024 International Congress

    Cholinergic Basal Forebrain Integrity and Cognition in Parkinson’s Disease

    N. Slater, T. Melzer, D. Myall, G. Hall-Mcmaster, A. Harris, K-L. Horne, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine the association between the integrity of the cholinergic basal forebrain (cBF) and cognition in Parkinson’s disease (PD). Background: Most PD patients experience…
  • 2024 International Congress

    Comparative assessment of cognitive functions of patients with ET and ET plus.

    M. Ermakova, Z. Zalyalova, S. Munasipova (Kazan, Russian Federation)

    Objective: to conduct a comparative analysis of changes in neurological status and cognitive decline of various types of essential tremor (ET). Background: in the new…
  • 2024 International Congress

    CANVAS: think to assess cognition!

    K. Dujardin, C. Tard, E. Diglé, V. Herlin, E. Mutez, JB. Davion, A. Wissocq, V. Delforge, G. Kuchcinski, V. Huin (Lille, France)

    Objective: To determine the frequency and severity of cognitive impairment in RFC1-positive patients and comprehensively describe the pattern of cognitive disorders. Background: Cerebellar ataxia, neuropathy,…
  • 2024 International Congress

    SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients

    J. Montillot, A. Gil-Salcedo, R. Massart, M. Lunven, A. Petit, A. Dormeuil, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)

    Objective: Use a news automated, motor-controlled cognitive battery, the SelfCog®, to compare cognitive deficits in PD patients. Background: Mild cognitive impairment (MCI) is a major…
  • 2024 International Congress

    How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored differences in communication abilities in people with Parkinson’s disease (PwP) with mild cognitive impairment (MCI) (PwP-MCI) and those with normal cognition (PwP-CN).…
  • 2024 International Congress

    Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

    Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…
  • 2024 International Congress

    Parkinson Patients` Motor and Cognitive Functions are Improved by High Intensity LSVT®BIG Physiotherapy – a Randomized Prospective Pilot Trial

    B. Wimmer, B. Budeus, M. Katzer, C. Preiner, T. Wächter, K. Seppi, U. Bogdahn (Innsbruck, Austria)

    Objective: The objective of this pilot study was to evaluate the potential efficacy of high intensity physiotherapy LSVT®BIG on motor and non-motor functions of PD…
  • 2024 International Congress

    Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

    I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)

    Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
  • 2024 International Congress

    Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis.

    A-M. Hanff, C. Mccrum, A. Rauschenberger, S. Pachchek, G. Aguayo, C. Pauly, S. Jónsdóttir, O. Tsurkalenko, L. Pauly, Z. Landoulsi, A. Leist, P. May, M. Zeegers, R. Krüger (Strassen, Luxembourg)

    Objective: To compare progression of motor- and non-motor symptoms in people with Parkinson’s disease (PD) with Gaucher-related gene glucocerebrosidase (GBA1) variants compared to people with…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley